Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Perceived stress, cytomegalovirus titers, and late-differentiated T and NK cells: Between-, within-person associations in a longitudinal study of older adults.

Reed RG, Presnell SR, Al-Attar A, Lutz CT, Segerstrom SC.

Brain Behav Immun. 2019 Aug;80:266-274. doi: 10.1016/j.bbi.2019.03.018. Epub 2019 Mar 15.

PMID:
30885843
2.

A longitudinal study of the stability, variability, and interdependencies among late-differentiated T and NK cell subsets in older adults.

Reed RG, Al-Attar A, Presnell SR, Lutz CT, Segerstrom SC.

Exp Gerontol. 2019 Jul 1;121:46-54. doi: 10.1016/j.exger.2019.03.006. Epub 2019 Mar 15.

PMID:
30885717
3.

Human Body Composition and Immunity: Visceral Adipose Tissue Produces IL-15 and Muscle Strength Inversely Correlates with NK Cell Function in Elderly Humans.

Al-Attar A, Presnell SR, Clasey JL, Long DE, Walton RG, Sexton M, Starr ME, Kern PA, Peterson CA, Lutz CT.

Front Immunol. 2018 Mar 6;9:440. doi: 10.3389/fimmu.2018.00440. eCollection 2018.

4.

Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans.

Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT.

Data Brief. 2016 Jun 15;8:536-44. doi: 10.1016/j.dib.2016.06.006. eCollection 2016 Sep.

5.

The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men.

Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT.

Mech Ageing Dev. 2016 Jun;156:25-33. doi: 10.1016/j.mad.2016.04.001. Epub 2016 Apr 6.

PMID:
27059724
6.

Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.

Hart JD, Lutz CT, Jennings CD, May JR, Nelson K, Jacobs S, Hoopes CW.

Transplant Proc. 2015 Apr;47(3):831-3. doi: 10.1016/j.transproceed.2014.12.022.

PMID:
25891741
7.

Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs.

Presnell SR, Al-Attar A, Cichocki F, Miller JS, Lutz CT.

Genes Immun. 2015 Jan-Feb;16(1):89-98. doi: 10.1038/gene.2014.65. Epub 2014 Nov 20.

8.

Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.

Lutz CT.

Curr Opin Organ Transplant. 2014 Aug;19(4):436-41. doi: 10.1097/MOT.0000000000000103. Review.

9.

Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient.

Lutz CT, Al-Attar A, May JR, Jennings CD.

Transplantation. 2014 Oct 27;98(8):853-6. doi: 10.1097/TP.0000000000000213.

PMID:
24914571
10.

Broadly reactive anti-HLA antibodies after a single unit transfusion with nonleukoreduced red blood cells.

Lutz CT, Macivor D, Rayapati P, Jennings CD.

Am Surg. 2014 Mar;80(3):E97-8. Review. No abstract available.

PMID:
24666858
11.

IL-2/IL-15 activate the human clonally restricted KIR3DL1 reverse promoter.

Presnell SR, Chan HW, Zhang L, Lutz CT.

Genes Immun. 2013 Mar;14(2):107-14. doi: 10.1038/gene.2012.62. Epub 2013 Jan 17.

12.
13.

Psychosocial resources, aging, and natural killer cell terminal maturity.

Segerstrom SC, Al-Attar A, Lutz CT.

Psychol Aging. 2012 Dec;27(4):892-902. doi: 10.1037/a0029093. Epub 2012 Jun 18.

14.

Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditions.

Presnell SR, Zhang L, Chlebowy CN, Al-Attar A, Lutz CT.

J Immunol. 2012 May 1;188(9):4394-404. doi: 10.4049/jimmunol.1103352. Epub 2012 Mar 30.

15.

Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Cichocki F, Felices M, McCullar V, Presnell SR, Al-Attar A, Lutz CT, Miller JS.

J Immunol. 2011 Dec 15;187(12):6171-5. doi: 10.4049/jimmunol.1100835. Epub 2011 Nov 14.

16.

Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.

Lutz CT, Karapetyan A, Al-Attar A, Shelton BJ, Holt KJ, Tucker JH, Presnell SR.

J Immunol. 2011 Apr 15;186(8):4590-8. doi: 10.4049/jimmunol.1002732. Epub 2011 Mar 14.

17.

Proteasome regulation of ULBP1 transcription.

Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT.

J Immunol. 2009 May 15;182(10):6600-9. doi: 10.4049/jimmunol.0801214.

18.

Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Binyamin L, Alpaugh RK, Hughes TL, Lutz CT, Campbell KS, Weiner LM.

J Immunol. 2008 May 1;180(9):6392-401.

19.

Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.

McCullar V, Oostendorp R, Panoskaltsis-Mortari A, Yun G, Lutz CT, Wagner JE, Miller JS.

Exp Hematol. 2008 May;36(5):598-608. doi: 10.1016/j.exphem.2008.01.001. Epub 2008 Mar 4.

20.

Functional redundancy of transcription factor-binding sites in the killer cell Ig-like receptor (KIR) gene promoter.

Presnell SR, Zhang L, Ramilo CA, Chan HW, Lutz CT.

Int Immunol. 2006 Aug;18(8):1221-32. Epub 2006 Jul 3.

PMID:
16818466
21.

Epigenetic control of highly homologous killer Ig-like receptor gene alleles.

Chan HW, Miller JS, Moore MB, Lutz CT.

J Immunol. 2005 Nov 1;175(9):5966-74.

22.

Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.

Rayhill SC, Kirby PA, Voigt MD, La Brecque DR, Lutz CT, Katz DA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Heisey D, Wu YM, Schmidt WN.

Transplantation. 2005 Aug 27;80(4):448-56.

PMID:
16123717
23.

Reciprocal age related change in natural killer cell receptors for MHC class I.

Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK.

Mech Ageing Dev. 2005 Jun-Jul;126(6-7):722-31. Epub 2005 Feb 19.

24.

Distress and expression of natural killer receptors on lymphocytes.

Lutgendorf SK, Moore MB, Bradley S, Shelton BJ, Lutz CT.

Brain Behav Immun. 2005 May;19(3):185-94.

PMID:
15797305
25.

Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18.

Moore MB, Kurago ZB, Fullenkamp CA, Lutz CT.

Cancer Immunol Immunother. 2003 Feb;52(2):107-15. Epub 2003 Jan 31.

PMID:
12594574
26.

DNA methylation maintains allele-specific KIR gene expression in human natural killer cells.

Chan HW, Kurago ZB, Stewart CA, Wilson MJ, Martin MP, Mace BE, Carrington M, Trowsdale J, Lutz CT.

J Exp Med. 2003 Jan 20;197(2):245-55.

27.

Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.

Reber AJ, Turnquist HR, Thomas HJ, Lutz CT, Solheim JC.

Immunogenetics. 2002 May;54(2):74-81. Epub 2002 Mar 23.

PMID:
12037599
28.
29.

HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins.

Turnquist HR, Thomas HJ, Prilliman KR, Lutz CT, Hildebrand WH, Solheim JC.

Eur J Immunol. 2000 Oct;30(10):3021-8.

30.
31.

Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women.

Chiu BC, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT, Wallace RB, Potter JD.

Br J Cancer. 1999 Jul;80(9):1476-82.

32.

Methylcholanthrene causes increased thymocyte apoptosis.

Lutz CT, Browne G, Petzold CR.

Toxicology. 1998 Jul 3;128(2):151-67.

PMID:
9710156
33.

Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes.

Lutz CT, Foster PA, Noll WW, Voelkerding KV, Press RD, McGlennen RC, Kirschbaum NE.

Clin Chem. 1998 Jun;44(6 Pt 1):1356-8. No abstract available.

PMID:
9625070
37.

Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.

Smith KD, Huczko E, Engelhard VH, Li YY, Lutz CT.

Transplantation. 1997 Jul 27;64(2):351-9.

PMID:
9256200
39.

Medical history risk factors for non-Hodgkin's lymphoma in older women.

Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT.

J Natl Cancer Inst. 1997 Feb 19;89(4):314-8.

PMID:
9048836
40.
41.

Resistance to Activated Protein C: Comparison of Three Different PCR Methods for Detection FV R506Q.

Voelkerding KV, Huber S, Strobl F, Wu LA, Sabatini LM, Anderson M, Lutz CT.

Mol Diagn. 1996 Dec;1(4):297-304.

PMID:
10462576
43.

Alloreactive anti-HLA-B7 cytolytic T cell clones use restricted T cell receptor genes.

Li YY, Smith KD, Shi Y, Lutz CT.

Transplantation. 1996 Oct 15;62(7):954-61.

PMID:
8878390
44.

Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.

Smith KD, Mace BE, Valenzuela A, Vigna JL, McCutcheon JA, Barbosa JA, Huczko E, Engelhard VH, Lutz CT.

J Immunol. 1996 Sep 15;157(6):2470-8.

PMID:
8805647
45.

Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.

Smith KD, Lutz CT.

J Immunol. 1996 May 15;156(10):3755-64.

PMID:
8621911
46.

Correction of the HLA-Cw3 genomic sequence tentatively identifies it as HLA-Cw*0304.

Zarling AL, Smith KD, Lutz CT, Lee DR.

Immunogenetics. 1996;44(1):82-3. No abstract available.

PMID:
8613148
47.

Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Smith KD, Epperson DF, Lutz CT.

Immunogenetics. 1996;43(1-2):27-37.

PMID:
8537119
48.

Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P.

J Exp Med. 1995 Jun 1;181(6):2085-95.

50.

Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.

Lutz CT, Smith KD, Greazel NS, Mace BE, Jensen DA, McCutcheon JA, Goeken NE.

J Immunol. 1994 Nov 1;153(9):4099-110.

PMID:
7523516

Supplemental Content

Support Center